美国与欧洲中轴型脊柱关节炎患者的治疗满意度、疾病严重程度及医疗资源使用比较
本研究基于2021年Adelphi axSpA疾病特定项目真实世界横断面调查,比较美国与五个欧洲国家中轴型脊柱关节炎患者的症状负担、医疗资源利用及医患对疾病严重程度和治疗满意度的一致性。结果显示美国患者数据收集时症状数更多,医患一致性较低,但过去12个月就诊次数较少,提示区域间存在诊疗差异。
要点
- 美国患者数据收集时平均症状数高于欧洲(3.3 vs 2.3,P<0.0001)。
- 美国医患对疾病严重程度和治疗满意度的一致性低于欧洲。
- 美国患者过去12个月平均就诊次数低于欧洲(5.2 vs 6.5,P=0.0008)。
核心结论
- 美国与欧洲中轴型脊柱关节炎患者在症状负担和诊疗利用上存在差异,识别诊疗差距有助于针对性改进治疗并减少健康不平等风险。
研究设计与样本
- 研究采用Adelphi axSpA疾病特定项目真实世界横断面调查,于2021年3月至11月在美国和五个欧洲国家开展,由风湿科医生连续报告患者数据。
- 共349名风湿科医生提供2750名患者数据(美国656例,欧洲2094例),其中1011例(36.8%)患者自报数据。
主要发现
- 数据收集时平均症状数美国为3.3(3.3),高于欧洲的2.3(2.8),差异有统计学意义(P<0.0001)。
- 医患对疾病严重程度的一致性(加权kappa)在诊断时美国为0.37、欧洲为0.47,治疗启动时美国为0.32、欧洲为0.42,数据收集时美国为0.32、欧洲为0.61。
- 医患对治疗满意度的一致性美国为0.35、欧洲为0.42。
- 过去12个月平均就诊次数美国为5.2(3.4),低于欧洲的6.5(5.1),差异有统计学意义(P=0.0008);平均住院次数相似。
临床怎么用
- 临床中应关注中轴型脊柱关节炎患者症状负担的区域差异,并重视医患对疾病严重程度和治疗满意度评估的一致性。
- 美国患者就诊次数较少但症状负担较重,提示需评估随访频率是否充分并针对性优化诊疗流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The heterogeneous presentation of axial SpA (axSpA) complicates diagnosis and treatment decisions. This study compared patient symptoms, health-care resource utilization, and physician-patient alignment on disease severity and treatment satisfaction between the USA and five European countries (5EU). METHODS: Data were drawn from the Adelphi axSpA Disease Specific Programme (DSP)™, a real-world cross-sectional survey conducted in the USA and 5EU between March and November 2021. Rheumatologists reported on consecutive patients, including clinical characteristics, disease severity, symptomatic burden, treatment history, health-care resource utilization, and treatment satisfaction. Patients reported on disease severity, treatment satisfaction, and other validated patient-reported outcome measures. Physician-patient alignment was quantified using weighted kappa analyses. RESULTS: A total of 349 rheumatologists provided data for 2750 patients (USA = 656, 5EU = 2094), of whom 1011 (36.8%) self-reported data. The mean (s.d.) numbers of symptoms at diagnosis were similar [USA: 6.0 (4.4) vs 5EU: 6.4 (4.3); P = 0.0657]; however, the mean [s.d.] numbers of symptoms at data collection was greater in the USA than in 5EU [3.3 (3.3) vs 2.3 (2.8), respectively; P < 0.0001]. Physician-patient alignment on disease severity at diagnosis (κ = 0.37 vs κ = 0.47), treatment initiation (κ = 0.32 vs κ = 0.42) and data collection (κ = 0.32 vs κ = 0.61), and treatment satisfaction (κ = 0.35 vs κ = 0.42) were lower in the USA than in 5EU. The mean [s.d.] number of consultations in the previous 12 months was lower in the USA than in 5EU [5.2 (3.4) vs 6.5 (5.1); P = 0.0008], although mean hospitalizations were similar. CONCLUSION: Differences in symptomatic burden and care were observed between regions. Identifying care gaps will aid in implementing targeted improvements in treatment, minimizing the risk of health inequalities.
引用
- Nikiphorou E, Ogdie A, Twigg D, et al. Treatment satisfaction, disease severity, and health-care use in patients with axial spondyloarthritis in the United States and Europe. Rheumatology (Oxford). 2026. PMID: 41863295. doi:10.1093/rheumatology/keag106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。